Wells Fargo’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32 | Hold |
154
| – | – | ﹤0.01% | 6206 |
|
|
2025
Q1 | $57 | Hold |
154
| – | – | ﹤0.01% | 5966 |
|
|
2024
Q4 | $136 | Hold |
154
| – | – | ﹤0.01% | 5889 |
|
|
2024
Q3 | $211 | Hold |
154
| – | – | ﹤0.01% | 5815 |
|
|
2024
Q2 | $345 | Sell |
154
-16
| -9% | -$36 | ﹤0.01% | 5787 |
|
|
2024
Q1 | $402 | Buy |
170
+8
| +5% | +$19 | ﹤0.01% | 5935 |
|
|
2023
Q4 | $1.09K | Hold |
162
| – | – | ﹤0.01% | 5761 |
|
|
2023
Q3 | $810 | Buy |
162
+1
| +0.6% | +$5 | ﹤0.01% | 5871 |
|
|
2023
Q2 | $1.6K | Buy |
161
+3
| +2% | +$30 | ﹤0.01% | 5940 |
|
|
2023
Q1 | $1.58K | Hold |
158
| – | – | ﹤0.01% | 5945 |
|
|
2022
Q4 | $3.47K | Hold |
158
| – | – | ﹤0.01% | 5542 |
|
|
2022
Q3 | $7K | Buy |
158
+1
| +0.6% | +$44 | ﹤0.01% | 5488 |
|
|
2022
Q2 | $9K | Hold |
157
| – | – | ﹤0.01% | 5506 |
|
|
2022
Q1 | $9K | Buy |
157
+154
| +5,133% | +$8.83K | ﹤0.01% | 5957 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 7068 |
|
|
2021
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 6427 |
|
|
2021
Q2 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 6890 |
|
|
2021
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 6825 |
|
|
2020
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 6482 |
|